Salvage Second Hematopoietic Cell Transplantation in Myeloma
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 01, 2013
- Source ID
- 10.1016/j.bbmt.2013.01.004
Entities
People
- Adetola A. Kassim
- Amrita Krishnan
- Angela Dispenzieri
- Angelo Maiolino
- Armin Ghobadi
- Ayman Saad
- Baldeep Wirk
- Bipin N Savani
- César O. Freytes
- Dan T. Vogl
- David H. Vesole
- David I. Marks
- Gary J. Schiller
- H. Kent Holland
- Harry C. Schouten
- Heather Landau
- Hillard M Lazarus
- Jan S. Moreb
- Jason Tay
- Jeffrey B Schriber
- Jennifer Le-Rademacher
- Jennifer M. Bird
- John Gibson
- Joseph Mikhael
- Julie M. Vose
- Kenneth C. Anderson
- Kenneth R. Meehan
- L. Bik To
- Laura C. Michaelis
- Leona Holmberg
- Matt E. Kalaycio
- Michael Lill
- Muneer H Abidi
- Parameswaran Hari
- Patrick J. Stiff
- Rajneesh Nath
- Rammurti T. Kamble
- Reinhold Munker
- Richard T. Maziarz
- Robert P. Gale
- Sagar Lonial
- Sergio A. Giralt
- Shaji K Kumar
- Taiga Nishihori
- Tamila Kindwall-keller
- Vivek Roy
- Wael Saber
- William Drobyski
- Xiaobo Zhong
Organizations
- ARIAD Pharmaceuticals
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- CellGenix (Germany)
- Children’s Leukemia Research Association
- Elevance Health, Inc.
- GSK
- Health Resources and Services Administration
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)